Sylogist Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Sylogist has a total shareholder equity of CA$36.1M and total debt of CA$19.0M, which brings its debt-to-equity ratio to 52.7%. Its total assets and total liabilities are CA$91.5M and CA$55.4M respectively. Sylogist's EBIT is CA$5.0M making its interest coverage ratio 2.8. It has cash and short-term investments of CA$5.0M.

Anahtar bilgiler

52.7%

Borç/özkaynak oranı

CA$19.03m

Borç

Faiz karşılama oranı	2.8x
Nakit	CA$5.05m
Eşitlik	CA$36.08m
Toplam yükümlülükler	CA$55.44m
Toplam varlıklar	CA$91.52m

Son finansal sağlık güncellemeleri

We Think Sylogist (TSE:SYZ) Can Stay On Top Of Its Debt

May 04

These 4 Measures Indicate That Sylogist (TSE:SYZ) Is Using Debt Reasonably Well

Oct 20

Recent updates

Sylogist Ltd. (TSE:SYZ) Shares Could Be 41% Below Their Intrinsic Value Estimate

Mar 27

Estimating The Intrinsic Value Of Sylogist Ltd. (TSE:SYZ)

Dec 16

Sylogist (TSE:SYZ) Has Affirmed Its Dividend Of CA$0.13

Nov 25

These 4 Measures Indicate That Sylogist (TSE:SYZ) Is Using Debt Reasonably Well

Oct 20

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SYZ's short term assets (CA$20.5M) do not cover its short term liabilities (CA$45.5M).

Uzun Vadeli Yükümlülükler: SYZ's short term assets (CA$20.5M) exceed its long term liabilities (CA$9.9M).

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SYZ's net debt to equity ratio (38.8%) is considered satisfactory.

Borcun Azaltılması: SYZ's debt to equity ratio has increased from 0% to 52.7% over the past 5 years.

Borç Kapsamı: SYZ's debt is well covered by operating cash flow (62.4%).

Faiz Kapsamı: SYZ's interest payments on its debt are not well covered by EBIT (2.8x coverage).

Sylogist Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

We Think Sylogist (TSE:SYZ) Can Stay On Top Of Its Debt

These 4 Measures Indicate That Sylogist (TSE:SYZ) Is Using Debt Reasonably Well

Recent updates

New minor risk - Insider selling

Independent Director recently sold CA$108k worth of stock

Independent Chairman exercised options to buy CA$216k worth of stock.

Second quarter dividend of CA$0.01 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Sylogist Ltd. Approves Dividend, Payable on September 11, 2024

Sylogist Ltd. to Report Q2, 2024 Results on Aug 08, 2024

Sylogist Ltd. Elects Aziz Benmalek as New Director

Consensus EPS estimates fall by 40%

First quarter dividend of CA$0.01 announced

Sylogist Ltd. Approves A Dividend, Payable on June 12, 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Sylogist Ltd. Approves A Dividend, Payable on June 12, 2024

Sylogist Ltd., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings: EPS misses analyst expectations

Sylogist Ltd. to Report Q4, 2023 Results on Mar 14, 2024

Third quarter dividend of CA$0.01 announced

Sylogist Ltd. Declares Quarterly Dividend, Payable on March 13, 2024

Sylogist Ltd. Announces Board Appointments

Pinning Down Sylogist Ltd.'s (TSE:SYZ) P/S Is Difficult Right Now

Price target increased by 12% to CA$11.00

Upcoming dividend of CA$0.01 per share at 0.6% yield

Sylogist Ltd. Approves Dividend, Payable on December 13, 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Sylogist Ltd. to Report Q3, 2023 Results on Nov 09, 2023

Price target increased by 13% to CA$11.10

Sylogist Ltd. Announces Changes Management Changes

Upcoming dividend of CA$0.01 per share at 0.5% yield

Sylogist Ltd. Approves Dividend, Payable on September 13, 2023

Second quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.037 profit in 2Q 2022)

Sylogist Ltd. to Report Q2, 2023 Results on Aug 10, 2023

Now 20% undervalued

Now 20% undervalued

New major risk - Revenue and earnings growth

Sylogist (TSE:SYZ) Could Be Struggling To Allocate Capital

Upcoming dividend of CA$0.01 per share at 0.7% yield

Sylogist Ltd. Declares A Dividend, Payable on June 14, 2023

First quarter 2023 earnings released: EPS: CA$0.004 (vs CA$0.029 in 1Q 2022)

Sylogist Ltd., Annual General Meeting, Jun 21, 2023

Sylogist Ltd. to Report Q1, 2023 Results on May 11, 2023

Now 23% undervalued after recent price drop

President recently bought CA$105k worth of stock

Now 26% undervalued after recent price drop

Now 20% undervalued

Upcoming dividend of CA$0.01 per share at 0.7% yield

Sylogist Ltd. Declares Quarterly Dividend, Payable on March 15, 2023

Sylogist (TSE:SYZ) Is Reinvesting At Lower Rates Of Return

Now 21% undervalued after recent price drop

Is Sylogist Ltd. (TSE:SYZ) Trading At A 29% Discount?

Sylogist Ltd. Appoints Grant McLarnon as Chief Revenue Officer

President recently bought CA$136k worth of stock

Upcoming dividend of CA$0.01 per share

Sylogist Ltd. Announces Retirement of Dave Elder as Executive Vice President and Corporate Secretary

Should You Investigate Sylogist Ltd. (TSE:SYZ) At CA$4.76?

Price target decreased to CA$9.38

Sylogist Ltd. Approves Quarterly Dividend, Payable on December 14, 2022

Sylogist Ltd. to Report Q4, 2022 Results on Nov 14, 2022

Sylogist (TSE:SYZ) Is Paying Out A Dividend Of CA$0.125

Consensus EPS estimates increase by 40%

Sylogist Ltd. Approves Quarterly Dividend, Payable on September 14, 2022

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Sylogist Ltd. to Report Q3, 2022 Results on Aug 11, 2022

High number of new directors

Independent Director recently bought CA$73k worth of stock

What Is Sylogist Ltd.'s (TSE:SYZ) Share Price Doing?

Executive VP & Corporate Secretary recently bought CA$83k worth of stock

Sylogist (TSE:SYZ) Will Pay A Dividend Of CA$0.13

Consensus EPS estimates fall by 38%

Price target decreased to CA$14.44

Sylogist Ltd. Approves Quarterly Dividend, Payable on June 15, 2022

Sylogist Ltd. to Report Q2, 2022 Results on May 12, 2022

We Think Sylogist (TSE:SYZ) Can Stay On Top Of Its Debt

High number of new and inexperienced directors